CUP-100 supports gene expression assay for cancer of unknown primary

External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site

Oct 22 / Springer Healthcare

CUP-ONE supports gene expression assay for cancer of unknown primary

Oncology Solid Tumours Pan-tumour ESMO-2023

Description

Watch Dr Harpreet Wasan explain the benefits of a joint gene expression and immunohistochemistry approach to identifying cancer of unknown primary origin.

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.